68:00 Hormones and synthetic substitutes
68:04.00 ADRENALS
BECLOMETHASONE DIPROPIONATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
50MCG Aerosol | 02242029 | QVAR | VAE |
100MCG Aerosol | 02242030 | QVAR | VAE |
BUDESONIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
3MG Capsule (Sustained Release) | 02229293 | ENTOCORT | TIL |
100MCG Powder | 00852074 | PULMICORT TURBUHALER | AZC |
200MCG Powder | 00851752 | PULMICORT TURBUHALER | AZC |
400MCG Powder | 00851760 | PULMICORT TURBUHALER | AZC |
0.125MG Suspension | 02465949 | TEVA-BUDESONIDE | TEV |
0.125MG/ML Suspension | 02229099 | PULMICORT NEBUAMP | AZC |
0.25MG/ML Suspension | 01978918 | PULMICORT NEBUAMP | AZC |
0.5MG Suspension | 02465957 | TEVA-BUDESONIDE | TEV |
0.5MG/ML Suspension | 01978926 | PULMICORT NEBUAMP | AZC |
CICLESONIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100MG/INHALATION Aerosol | 02285606 | ALVESCO | AZC |
200MG/INHALATION Aerosol | 02285614 | ALVESCO | AZC |
CORTISONE ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
25MG Tablet | 00280437 | CORTISONE | VAE |
DEXAMETHASONE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
0.1MG/ML Elixir | 01946897 | PMS DEXAMETHASONE | PMS |
0.5MG Tablet | 02261081 | APO-DEXAMETHASONE | APX |
0.5MG Tablet | 01964976 | PMS DEXAMETHASONE | PMS |
0.75MG Tablet | 01964968 | PMS DEXAMETHASONE | PMS |
2MG Tablet | 02279363 | PMS-DEXAMETHASONE | PMS |
4MG Tablet | 02250055 | APO-DEXAMETHASONE | APX |
4MG Tablet | 01964070 | PMS DEXAMETHASONE | PMS |
pDIN For Extemporaneous Mixture | 99503007 | DEXAMETHASONE ORAL LIQUID | UNK |
DEXAMETHASONE PHOSPHATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
4MG/ML Liquid | 00664227 | DEXAMETHASONE | SDZ |
4MG/ML Liquid | 01977547 | DEXAMETHASONE | RAX |
4MG/ML Liquid | 02204266 | DEXAMETHASONE-OMEGA | OMG |
10MG/ML Liquid | 00874582 | DEXAMETHASONE | SDZ |
10MG/ML Liquid | 02204274 | DEXAMETHASONE-OMEGA | OMG |
10MG/ML Liquid | 00783900 | PMS-DEXAMETHASONE | PMS |
FLUDROCORTISONE ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
0.1MG Tablet | 02086026 | FLORINEF | PAL |
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE
Limited use benefit (prior approval required).
For the maintenance treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema who meet the following criteria:
- patients are not started on triple inhaled therapy as initial therapy for COPD; and
- patients have had an inadequate response to optimal dual-inhaled therapy* for COPD.
*Dual-inhaled therapy refers to any combination of a long-acting muscarinic antagonist (LAMA), long-acting beta-2 agonist (LABA) or an inhaled corticosteroid (ICS).
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100MCG & 62.5MCG & 25MCG Powder | 02474522 | TRELEGY ELLIPTA | GSK |
FLUTICASONE PROPIONATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
50MCG/INHALATION Aerosol | 02244291 | FLOVENT HFA | GSK |
125MCG/INHALATION Aerosol | 02244292 | FLOVENT HFA | GSK |
250MCG/INHALATION Aerosol | 02244293 | FLOVENT HFA | GSK |
100MCG/DOSE Powder | 02237245 | FLOVENT DISKUS | GSK |
250MCG/DOSE Powder | 02237246 | FLOVENT DISKUS | GSK |
500MCG/DOSE Powder | 02237247 | FLOVENT DISKUS | GSK |
HYDROCORTISONE (HYDROCORTISONE SODIUM SUCCINATE)
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100MG Powder For Solution | 00030600 | SOLU-CORTEF ACT-O-VIAL | PFI |
250MG Powder For Solution | 00030619 | SOLU-CORTEF ACT-O-VIAL | PFI |
1G Powder For Solution | 00030635 | SOLU-CORTEF ACT-O-VIAL | PFI |
HYDROCORTISONE ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
10MG Tablet | 00030910 | CORTEF | PFI |
20MG Tablet | 00030929 | CORTEF | PFI |
METHYLPREDNISOLONE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
4MG Tablet | 00030988 | MEDROL | PFI |
16MG Tablet | 00036129 | MEDROL | PFI |
METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE)
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
40MG Injection | 02367947 | SOLU-MEDROL | PFI |
125MG Injection | 02367955 | SOLU-MEDROL | PFI |
500MG Injection | 00030678 | SOLU-MEDROL | PFI |
1G Injection | 00036137 | SOLU-MEDROL | PFI |
1G Injection | 02367971 | SOLU-MEDROL | PFI |
500MG Powder For Solution | 02231895 | METHYLPREDNISOLONE SODIUM SUCCINATE | TEV |
1G Powder For Solution | 02241229 | METHYLPREDNISOLONE SODIUM SUCCINATE | TEV |
METHYLPREDNISOLONE ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
20MG/ML Suspension | 01934325 | DEPO-MEDROL | PFI |
40MG/ML Suspension | 00030759 | DEPO-MEDROL | PFI |
40MG/ML Suspension | 01934333 | DEPO-MEDROL | PFI |
40MG/ML Suspension | 02245400 | METHYLPREDNISOLONE | SDZ |
40MG/ML Suspension | 02245407 | METHYLPREDNISOLONE | SDZ |
80MG/ML Suspension | 00030767 | DEPO-MEDROL | PFI |
80MG/ML Suspension | 01934341 | DEPO-MEDROL | PFI |
80MG/ML Suspension | 02245406 | METHYLPREDNISOLONE | SDZ |
80MG/ML Suspension | 02245408 | METHYLPREDNISOLONE | SDZ |
METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
40MG & 10MG Suspension | 00260428 | DEPO-MEDROL WITH LIDOCAINE | PFI |
MOMETASONE FUROATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
200MCG Powder | 02243595 | ASMANEX TWISTHALER | FRS |
400MCG Powder | 02243596 | ASMANEX TWISTHALER | FRS |
PREDNISOLONE SODIUM PHOSPHATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
1MG/ML Solution | 02230619 | PEDIAPRED | SAC |
1MG/ML Solution | 02245532 | PMS-PREDNISOLONE | PMS |
PREDNISONE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
1MG Tablet | 00598194 | APO PREDNISONE | APX |
1MG Tablet | 00271373 | WINPRED | AAP |
5MG Tablet | 00312770 | APO PREDNISONE | APX |
5MG Tablet | 00021695 | TEVA-PREDNISONE | TEV |
50MG Tablet | 00550957 | APO PREDNISONE | APX |
50MG Tablet | 00232378 | TEVA-PREDNISONE | TEV |
pDIN For Extemporaneous Mixture | 99503008 | PREDNISONE ORAL LIQUID | UNK |
TRIAMCINOLONE ACETONIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
40MG/ML Injection | 00990876 | KENALOG-40 | BMS |
10MG/ML Suspension | 01999761 | KENALOG-10 | BMS |
10MG/ML Suspension | 02229540 | TRIAMCINOLONE | SDZ |
40MG/ML Suspension | 01999869 | KENALOG-40 | BMS |
40MG/ML Suspension | 01977563 | TRIAMCINOLONE | RAX |
40MG/ML Suspension | 02229550 | TRIAMCINOLONE | SDZ |
TRIAMCINOLONE DIACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
40MG/ML Suspension | 01977555 | TRIAMCINOLONE | RAX |
TRIAMCINOLONE HEXACETONIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
20MG Suspension | 02470632 | TRIAMCINOLONE HEXACETONIDE INJECTABLE | UNK |
68:08.00 ANDROGENS
DANAZOL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
50MG Capsule | 02018144 | CYCLOMEN | SAC |
100MG Capsule | 02018152 | CYCLOMEN | SAC |
200MG Capsule | 02018160 | CYCLOMEN | SAC |
TESTOSTERONE (TOPICAL)
Limited use benefit (prior approval required).
The NIHB Program covers topical testosterone for the treatment of the following:
- orchiectomy, undescended testes, Klinefelter's; or
- pituitary tumour or post-pituitary surgery with low testosterone; or
- AIDS-wasting syndrome with low testosterone; or
- gender affirming hormone therapy.
Note: Older individuals with non-specific symptoms such as, but not limited to, fatigue, malaise, or depression who have a low random testosterone level do not meet coverage criteria.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
1% Gel | 02245345 | ANDROGEL | BGP |
1% Gel | 02245346 | ANDROGEL | BGP |
1% Gel | 02463792 | TARO-TESTOSTERONE | TAR |
1% Gel | 02463806 | TARO-TESTOSTERONE | TAR |
1% Gel | 02280248 | TESTIM | PAL |
12.5MG Gel | 02249499 | ANDROGEL | BGP |
2.5MG Patch | 02239653 | ANDRODERM | ALL |
5MG Patch | 02245972 | ANDRODERM | ALL |
TESTOSTERONE CYPIONATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100MG/ML Solution | 00030783 | DEPO-TESTOSTERONE | PFI |
100MG/ML Solution | 02246063 | TESTOSTERONE CYPIONATE | SDZ |
TESTOSTERONE ENANTHATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
200MG/ML Solution | 00029246 | DELATESTRYL | VAE |
TESTOSTERONE UNDECANOATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
40MG Capsule | 02322498 | PMS-TESTOSTERONE | PMS |
40MG Capsule | 02421186 | TARO-TESTOSTERONE | TAR |
68:12.00 CONTRACEPTIVES
DESOGESTREL, ETHINYL ESTRADIOL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST25MCG & 150MCG, 125MCG, 100MCG Tablet | 02272903 | LINESSA 21 | ASP |
ST25MCG & 150MCG, 125MCG, 100MCG Tablet | 02257238 | LINESSA 28 | ASP |
ETHINYL ESTRADIOL, DESOGESTREL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST30MCG & 150MCG Tablet | 02317192 | APRI 21 | TEV |
ST30MCG & 150MCG Tablet | 02317206 | APRI 28 | TEV |
ST30MCG & 150MCG Tablet | 02396491 | FREYA 21 | MYL |
ST30MCG & 150MCG Tablet | 02396610 | FREYA 28 | MYL |
ST30MCG & 150MCG Tablet | 02042487 | MARVELON 21 | FRS |
ST30MCG & 150MCG Tablet | 02042479 | MARVELON 28 | FRS |
ST30MCG & 150MCG Tablet | 02410249 | MIRVALA 21 | APX |
ST30MCG & 150MCG Tablet | 02410257 | MIRVALA 28 | APX |
ETHINYL ESTRADIOL, DROSPIRENONE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.02MG & 3MG Tablet | 02415380 | MYA | APX |
ST0.02MG & 3MG Tablet | 02321157 | YAZ | BAY |
ST0.03MG & 3MG Tablet | 02261723 | YASMIN 21 | BAY |
ST0.03MG & 3MG Tablet | 02261731 | YASMIN 28 | BAY |
ST0.03MG & 3MG Tablet | 02410788 | ZAMINE 21 | APX |
ST0.03MG & 3MG Tablet | 02410796 | ZAMINE 28 | APX |
ETHINYL ESTRADIOL, ETONOGESTREL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST2.6MG & 11.4MG Ring (Slow-Release) | 02253186 | NUVARING | FRS |
ETHINYL ESTRADIOL, LEVONORGESTREL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.03MG & 0.15MG Tablet | 02398869 | INDAYO | MYL |
ST0.15MG & 0.03MG Tablet | 02296659 | SEASONALE | TEV |
ST20MCG & 100MCG Tablet | 02236974 | ALESSE 21 | PFI |
ST20MCG & 100MCG Tablet | 02236975 | ALESSE 28 | PFI |
ST20MCG & 100MCG Tablet | 02387875 | ALYSENA 21 | APX |
ST20MCG & 100MCG Tablet | 02387883 | ALYSENA 28 | APX |
ST20MCG & 100MCG Tablet | 02298538 | AVIANE 21 | TEV |
ST20MCG & 100MCG Tablet | 02298546 | AVIANE 28 | TEV |
ST30MCG & 0.05MG, 40MCG & 0.075MG, 30MCG & 0.125MG Tablet | 00707600 | TRIQUILAR 21 | BAY |
ST30MCG & 0.05MG, 40MCG & 0.075MG, 30MCG & 0.125MG Tablet | 00707503 | TRIQUILAR 28 | BAY |
ST30MCG & 150MCG Tablet | 02042320 | MIN-OVRAL 21 | PFI |
ST30MCG & 150MCG Tablet | 02042339 | MIN-OVRAL 28 | PFI |
ST30MCG & 150MCG Tablet | 02387085 | OVIMA 21 | APX |
ST30MCG & 150MCG Tablet | 02387093 | OVIMA 28 | APX |
ST30MCG & 150MCG Tablet | 02295946 | PORTIA 21 | TEV |
ST30MCG & 150MCG Tablet | 02295954 | PORTIA 28 | TEV |
ETHINYL ESTRADIOL, NORELGESTROMIN
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST6MG & 0.6MG Patch (Extended Release) | 02248297 | EVRA | JSO |
ETHINYL ESTRADIOL, NORETHINDRONE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
35MCG & 0.5MG Tablet | 02187086 | BREVICON 0.5/35 (21-DAY PACK) | PFI |
ST35MCG & 0.5MG Tablet | 02187094 | BREVICON 0.5/35 (28-DAY PACK) | PFI |
ST35MCG & 1MG Tablet | 02189054 | BREVICON 1/35 (21-DAY PACK) | PFI |
ST35MCG & 1MG Tablet | 02189062 | BREVICON 1/35 (28-DAY PACK) | PFI |
ST35MCG & 1MG Tablet | 02197502 | SELECT 1/35 (21-DAY) | PFI |
ST35MCG & 1MG Tablet | 02199297 | SELECT 1/35 (28-DAY) | PFI |
ETHINYL ESTRADIOL, NORETHINDRONE ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST10MCG & 1MG Tablet | 02417456 | LOLO | ALL |
ST20MCG & 1MG Tablet | 00315966 | MINESTRIN 1/20 (21-DAY) | ALL |
ST20MCG & 1MG Tablet | 00343838 | MINESTRIN 1/20 (28-DAY) | ALL |
ST30MCG & 1.5MG Tablet | 00297143 | LOESTRIN | ALL |
ST30MCG & 1.5MG Tablet | 00353027 | LOESTRIN | ALL |
ETHINYL ESTRADIOL, NORGESTIMATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST35MCG & 0.25MG Tablet | 01968440 | CYCLEN (21 DAY) | JSO |
ST35MCG & 0.25MG Tablet | 01992872 | CYCLEN (28 DAY) | JSO |
LEVONORGESTREL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
19.5MG Insert (Extended-Release) | 02459523 | KYLEENA | BAY |
0.75MG Tablet | 02371189 | OPTION 2 | PER |
1.5MG Tablet | 02433532 | BACKUP PLAN ONESTEP | APX |
1.5MG Tablet | 02425009 | CONTINGENCY ONE | MYL |
1.5MG Tablet | 02293854 | PLAN B | UNK |
LEVONORGESTREL INTRAUTERINE INSERT
Limited use benefit with quantity and frequency limits (prior approval is not required).
Coverage is granted for 1 device every 2 years.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
52MG Insert (Extended-Release) | 02243005 | MIRENA | BAY |
LEVONORGESTREL, ETHINYL ESTRADIOL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.15MG & 0.03MG & 0.01MG Tablet | 02346176 | SEASONIQUE | TEV |
NORETHINDRONE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.35MG Tablet | 02441306 | JENCYCLA | LUP |
ST0.35MG Tablet | 00037605 | MICRONOR 28-DAY | JSO |
ST0.35MG Tablet | 02410303 | MOVISSE | MYL |
NORETHINDRONE, ETHINYL ESTRADIOL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
35MCG & 0.5MG, 35MCG & 1MG Tablet | 02187108 | SYNPHASIC 21 | PFI |
ST35MCG & 0.5MG, 35MCG & 1MG Tablet | 02187116 | SYNPHASIC 28 | PFI |
NORGESTIMATE, ETHINYL ESTRADIOL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.25MG & 0.035MG Tablet | 02486318 | TRI-JORDYNA 28 | GLK |
ST25MCG & 0.180MG, 25MCG & 0.215MG, 25MCG & 0.25MG Tablet | 02401967 | TRICIRA LO 21 | APX |
ST25MCG & 0.180MG, 25MCG & 0.215MG, 25MCG & 0.25MG Tablet | 02401975 | TRICIRA LO 28 | APX |
ST25MCG & 0.180MG, 25MCG & 0.215MG, 25MCG & 0.25MG Tablet | 02258560 | TRI-CYCLEN LO (21 DAY) | JSO |
ST25MCG & 0.180MG, 25MCG & 0.215MG, 25MCG & 0.25MG Tablet | 02258587 | TRI-CYCLEN LO (28 DAY) | JSO |
ST35MCG & 0.180MG, 35MCG & 0.215MG, 35MCG & 0.25MG Tablet | 02028700 | TRI-CYCLEN 21-DAY | JSO |
ST35MCG & 0.180MG, 35MCG & 0.215MG, 35MCG & 0.25MG Tablet | 02029421 | TRI-CYCLEN 28-DAY | JSO |
ULIPRISTAL ACETATE
Limited use benefit (prior approval not required).
For the preoperative treatment of moderate-to-severe signs and symptoms of uterine fibroids in adult clients of reproductive age; and for the intermittent treatment of moderate-to-severe signs and symptoms of uterine fibroids in adult clients of reproductive age who are not eligible for surgery, with the duration of each treatment course being three months, if the following conditions are met:
- the patient is under the care of an obstetrician/gynecologist.
- patients receiving ulipristal acetate should have their liver function tests monitored before, during, and after treatment.
Coverage will be limited to a maximum of four courses of therapy for clients aged 18 to 60 years.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST5MG Tablet | 02408163 | FIBRISTAL | ALL |
68:16.04 ESTROGENS
CONJUGATED ESTROGENS
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.625MG/G Cream | 02043440 | PREMARIN | PFI |
ST0.3MG Tablet (Extended Release) | 02414678 | PREMARIN | PFI |
ST0.625MG Tablet (Extended Release) | 02414686 | PREMARIN | PFI |
ST1.25MG Tablet (Extended Release) | 02414694 | PREMARIN | PFI |
ESTRADIOL
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.25MG Gel | 02424924 | DIVIGEL | SEA |
ST0.5MG Gel | 02424835 | DIVIGEL | SEA |
ST1MG Gel | 02424843 | DIVIGEL | SEA |
ST25MCG Patch | 02245676 | ESTRADOT 25 | NVR |
ST25MCG Patch | 02243722 | OESCLIM | SEA |
ST37.5MCG Patch | 02243999 | ESTRADOT 37.5 | NVR |
ST50MCG Patch | 02244000 | ESTRADOT 50 | NVR |
ST50MCG Patch | 02243724 | OESCLIM | SEA |
ST75MCG Patch | 02244001 | ESTRADOT 75 | NVR |
ST100MCG Patch | 02244002 | ESTRADOT 100 | NVR |
ST2MG Ring (Slow-Release) | 02168898 | ESTRING | PFI |
ST0.5MG Tablet | 02225190 | ESTRACE | TRM |
ST1MG Tablet | 02148587 | ESTRACE | TRM |
ST2MG Tablet | 02148595 | ESTRACE | TRM |
ESTRADIOL HEMIHYDRATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.06% Gel | 02238704 | ESTROGEL | FRS |
ST25MCG Patch | 02247499 | CLIMARA 25 | BAY |
ST50MCG Patch | 02231509 | CLIMARA 50 | BAY |
ST50MCG Patch | 02246967 | SANDOZ ESTRADIOL DERM | SDZ |
ST75MCG Patch | 02247500 | CLIMARA 75 | BAY |
ST75MCG Patch | 02246968 | SANDOZ ESTRADIOL DERM | SDZ |
ST100MCG Patch | 02246969 | SANDOZ ESTRADIOL DERM | SDZ |
ST0.5MG Tablet | 02449048 | LUPIN-ESTRADIOL | LUP |
ST1MG Tablet | 02449056 | LUPIN-ESTRADIOL | LUP |
ST2MG Tablet | 02449064 | LUPIN-ESTRADIOL | LUP |
ST10MCG Vaginal Tablet | 02325462 | VAGIFEM 10 | NOO |
ESTRADIOL, NORETHINDRONE ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST50MCG & 140MCG Patch | 02241835 | ESTALIS | NVR |
ST50MCG & 250MCG Patch | 02241837 | ESTALIS | NVR |
ESTRONE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST1MG/G Cream | 00727369 | ESTRAGYN | SEA |
68:16.12 ESTROGEN AGONISTS-ANTAGONISTS
RALOXIFENE HYDROCHLORIDE
Limited use benefit (prior approval required).
For secondary prevention of osteoporosis in clients who experience failure on bisphosphonates; or
For secondary prevention of osteoporosis in clients who have a personal history or a first degree relative with a history of breast cancer.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
60MG Tablet | 02358840 | ACT RALOXIFENE | TEV |
60MG Tablet | 02279215 | APO-RALOXIFENE | APX |
60MG Tablet | 02239028 | EVISTA | LIL |
68:18.00 GONADOTROPINS
GOSERELIN ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
3.6MG/DEPOT Implant | 02049325 | ZOLADEX | UNK |
NAFARELIN ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
2MG/ML Aerosol | 02188783 | SYNAREL | PFI |
68:18.04
DEGARELIX ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
80MG Powder For Solution | 02337029 | FIRMAGON | FEI |
120MG Powder For Solution | 02337037 | FIRMAGON | FEI |
68:18.08
LEUPROLIDE ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
3.75MG/VIAL Powder For Suspension | 00884502 | LUPRON DEPOT | ABV |
7.5MG/VIAL Powder For Suspension | 00836273 | LUPRON DEPOT | ABV |
11.25MG/VIAL Powder For Suspension | 02239834 | LUPRON DEPOT | ABV |
22.5MG/VIAL Powder For Suspension | 02230248 | LUPRON DEPOT | ABV |
30MG/VIAL Powder For Suspension | 02239833 | LUPRON DEPOT | ABV |
68:20.02 ALPHA-GLUCOSIDASE INHIBITORS
ACARBOSE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST50MG Tablet | 02190885 | GLUCOBAY | BAY |
ST50MG Tablet | 02494078 | MAR-ACARBOSE | MAR |
ST100MG Tablet | 02190893 | GLUCOBAY | BAY |
ST100MG Tablet | 02494086 | MAR-ACARBOSE | MAR |
68:20.04 BIGUANIDES
METFORMIN HYDROCHLORIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST500MG Tablet | 02257726 | ACT METFORMIN | TEV |
ST500MG Tablet | 02167786 | APO-METFORMIN | APX |
ST500MG Tablet | 02438275 | AURO-METFORMIN | AUR |
ST500MG Tablet | 02229994 | DOM-METFORMIN | DPC |
ST500MG Tablet | 02099233 | GLUCOPHAGE | SAC |
ST500MG Tablet | 02229516 | GLYCON | VAE |
ST500MG Tablet | 02380196 | JAMP-METFORMIN | JMP |
ST500MG Tablet | 02353377 | METFORMIN | SAN |
ST500MG Tablet | 02378841 | METFORMIN | MAR |
ST500MG Tablet | 02385341 | METFORMIN FC | SIV |
ST500MG Tablet | 02223562 | PMS-METFORMIN | PMS |
ST500MG Tablet | 02314908 | PRO-METFORMIN | PDL |
ST500MG Tablet | 02269031 | RAN-METFORMIN | RBY |
ST500MG Tablet | 02242974 | RATIO-METFORMIN | TEV |
ST500MG Tablet | 02239081 | RIVA-METFORMIN | RIV |
ST500MG Tablet | 02246820 | SANDOZ METFORMIN FC | SDZ |
ST500MG Tablet | 02379767 | SEPTA-METFORMIN | SPT |
ST850MG Tablet | 02257734 | ACT METFORMIN | TEV |
ST850MG Tablet | 02229785 | APO-METFORMIN | APX |
ST850MG Tablet | 02438283 | AURO-METFORMIN | AUR |
ST850MG Tablet | 02242726 | DOM-METFORMIN | DPC |
ST850MG Tablet | 02162849 | GLUCOPHAGE | SAC |
ST850MG Tablet | 02239214 | GLYCON | VAE |
ST850MG Tablet | 02380218 | JAMP-METFORMIN | JMP |
ST850MG Tablet | 02353385 | METFORMIN | SAN |
ST850MG Tablet | 02378868 | METFORMIN | MAR |
ST850MG Tablet | 02385368 | METFORMIN FC | SIV |
ST850MG Tablet | 02242589 | PMS-METFORMIN | PMS |
ST850MG Tablet | 02314894 | PRO-METFORMIN | PDL |
ST850MG Tablet | 02269058 | RAN-METFORMIN | RBY |
ST850MG Tablet | 02242931 | RATIO-METFORMIN | TEV |
ST850MG Tablet | 02242783 | RIVA-METFORMIN | RIV |
ST850MG Tablet | 02246821 | SANDOZ METFORMIN | SDZ |
ST850MG Tablet | 02379775 | SEPTA-METFORMIN | SPT |
68:20.05 DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS
LINAGLIPTIN
Open benefit.
For the treatment of patients with type 2 diabetes mellitus who did not achieve glycemic control or who demonstrated intolerance to an adequate trial of metformin and a sulfonylurea.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST5MG Tablet | 02370921 | TRAJENTA | BOE |
LINAGLIPTIN, METFORMIN HYDROCHLORIDE
Open benefit.
- For the treatment of patients with type 2 diabetes mellitus who did not achieve glycemic control or who demonstrated intolerance to an adequate trial of metformin and a sulfonylurea.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST2.5MG & 1000MG Tablet | 02403277 | JENTADUETO | BOE |
ST2.5MG & 500MG Tablet | 02403250 | JENTADUETO | BOE |
ST2.5MG & 850MG Tablet | 02403269 | JENTADUETO | BOE |
SAXAGLIPTIN HYDROCHLORIDE
Open benefit.
For the treatment of patients with type 2 diabetes mellitus who did not achieve glycemic control or who demonstrated intolerance to an adequate trial of metformin and a sulfonylurea.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST2.5MG Tablet | 02375842 | ONGLYZA | AZC |
ST5MG Tablet | 02333554 | ONGLYZA | AZC |
SAXAGLIPTIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE
Open benefit.
For the treatment of patients with type 2 diabetes mellitus who did not achieve glycemic control or who demonstrated intolerance to an adequate trial of metformin and a sulfonylurea.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST2.5MG & 1000MG Tablet | 02389185 | KOMBOGLYZE | AZC |
ST2.5MG & 500MG Tablet | 02389169 | KOMBOGLYZE | AZC |
ST2.5MG & 850MG Tablet | 02389177 | KOMBOGLYZE | AZC |
SITAGLIPTIN PHOSPHATE MONOHYDRATE
Limited use benefit (prior approval required).
For the treatment of patients with type 2 diabetes mellitus who did not achieve glycemic control or who demonstrated intolerance to an adequate trial of metformin and a sulfonylurea.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST25MG Tablet | 02388839 | JANUVIA | FRS |
ST50MG Tablet | 02388847 | JANUVIA | FRS |
ST100MG Tablet | 02303922 | JANUVIA | FRS |
SITAGLIPTIN PHOSPHATE MONOHYDRATE, METFORMIN HYDROCHLORIDE
Limited use benefit (prior approval required).
For the treatment of patients with type 2 diabetes mellitus who did not achieve glycemic control or who demonstrated intolerance to an adequate trial of metformin and a sulfonylurea.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST50MG & 1000MG Tablet | 02333872 | JANUMET | FRS |
ST50MG & 500MG Tablet | 02333856 | JANUMET | FRS |
ST50MG & 850MG Tablet | 02333864 | JANUMET | FRS |
ST50MG & 1000MG Tablet (Extended Release) | 02416794 | JANUMET XR | FRS |
ST50MG & 500MG Tablet (Extended Release) | 02416786 | JANUMET XR | FRS |
ST100MG & 1000MG Tablet (Extended Release) | 02416808 | JANUMET XR | FRS |
68:20.06 INCRETIN MIMETICS
LIXISENATIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
10MCG Solution | 02464276 | ADLYXINE | SAC |
20MCG Solution | 02464284 | ADLYXINE | SAC |
SEMAGLUTIDE
Open benefit.
For the treatment of type 2 diabetes in combination with metformin alone, when diet and exercise plus maximal tolerated dose of metformin do not achieve adequate glycemic control.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
1MG Solution | 02471469 | OZEMPIC | NOO |
1.34MG Solution | 02471477 | OZEMPIC | NOO |
68:20.08 INSULINS
INSULIN (30% NEUTRAL & 70% ISOPHANE) HUMAN BIOSYNTHETIC
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 00795879 | HUMULIN 30/70 | LIL |
100U/ML Injection | 01959212 | HUMULIN 30/70 CARTRIDGE | LIL |
100U/ML Injection | 09853855 | HUMULIN 30/70 CARTRIDGE | LIL |
100U/ML Injection | 02024217 | NOVOLIN GE 30/70 | NOO |
100U/ML Injection | 02025248 | NOVOLIN GE 30/70 PENFILL | NOO |
100U/ML Injection | 09853812 | NOVOLIN GE 30/70 PENFILL | NOO |
INSULIN (40% NEUTRAL & 60% ISOPHANE) HUMAN BIOSYNTHETIC
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 02024314 | NOVOLIN GE 40/60 PENFILL | NOO |
INSULIN (50% NEUTRAL & 50% ISOPHANE) HUMAN BIOSYNTHETIC
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 02024322 | NOVOLIN GE 50/50 PENFILL | NOO |
INSULIN (ISOPHANE) HUMAN BIOSYNTHETIC
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 00587737 | HUMULIN N | LIL |
100U/ML Injection | 01959239 | HUMULIN N (CARTRIDGE) | LIL |
100U/ML Injection | 02403447 | HUMULIN N (KWIKPEN) | LIL |
100U/ML Injection | 09853804 | HUMULIN N 100U/ML (CARTRIDGE) | LIL |
100U/ML Injection | 02024225 | NOVOLIN GE NPH | NOO |
100U/ML Injection | 09853782 | NOVOLIN GE NPH 100U/ML PENFILL | NOO |
100U/ML Injection | 02024268 | NOVOLIN GE NPH PENFILL | NOO |
INSULIN (ZINC CRYSTALLINE) HUMAN BIOSYNTHETIC (RDNA ORIGIN)
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 00586714 | HUMULIN R | LIL |
100U/ML Injection | 09853766 | HUMULIN R 100U/ML (CARTRIDGE) | LIL |
100U/ML Injection | 01959220 | HUMULIN R CARTRIDGE | LIL |
INSULIN ASPART
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 02244353 | NOVORAPID | NOO |
100U/ML Injection | 02245397 | NOVORAPID | NOO |
100U/ML Injection | 02377209 | NOVORAPID | NOO |
INSULIN BIOSYNTHETIC HUMAN BR
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U Solution | 02415089 | HUMULIN R (KWIKPEN) | LIL |
INSULIN DEGLUDEC
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U Solution | 02467879 | TRESIBA | NOO |
200U Solution | 02467887 | TRESIBA | NOO |
INSULIN DETEMIR
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 02412829 | LEVEMIR FLEXTOUCH | NOO |
100U/ML Injection | 02271842 | LEVEMIR PENFILL | NOO |
INSULIN GLARGINE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 02245689 | LANTUS | SAC |
100U/ML Injection | 02251930 | LANTUS | SAC |
100U/ML Injection | 02294338 | LANTUS SOLOSTAR | SAC |
100U Solution | 02444844 | BASAGLAR | LIL |
100U Solution | 02461528 | BASAGLAR | LIL |
300U Solution | 02441829 | TOUJEO SOLOSTAR | SAC |
INSULIN GLULISINE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 02279479 | APIDRA CARTRIDGE | SAC |
100U/ML Injection | 02294346 | APIDRA SOLOSTAR | SAC |
100U/ML Injection | 02279460 | APIDRA VIAL | SAC |
INSULIN HUMAN BIOSYNTHETIC
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 02024233 | NOVOLIN GE TORONTO | NOO |
100U/ML Injection | 02024284 | NOVOLIN GE TORONTO PENFILL | NOO |
100U/ML Injection | 09853774 | NOVOLIN GE TORONTO PENFILL | NOO |
INSULIN LISPRO
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 02229704 | HUMALOG | LIL |
100U/ML Injection | 02229705 | HUMALOG (CARTRIDGE) | LIL |
100U/ML Injection | 02403412 | HUMALOG (KWIKPEN) | LIL |
100U/ML Injection | 09853715 | HUMALOG 100U/ML CARTRIDGE | LIL |
200U/ML Injection | 02439611 | HUMALOG 200U/ML KWIKPEN | LIL |
100U Solution | 02470152 | HUMALOG | LIL |
INSULIN LISPRO, INSULIN LISPRO PROTAMINE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100U/ML Injection | 02240294 | HUMALOG MIX 25 (CARTRIDGE) | LIL |
100U/ML Injection | 02403420 | HUMALOG MIX 25 (KWIKPEN) | LIL |
100U/ML Injection | 02240297 | HUMALOG MIX 50 (CARTRIDGE) | LIL |
100U/ML Injection | 02403439 | HUMALOG MIX 50 (KWIKPEN) | LIL |
LIXISENATIDE, INSULIN GLARGINE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
33MCG & 100U Solution | 02478293 | SOLIQUA | SAC |
68:20.16 MEGLITINIDES
REPAGLINIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.5MG Tablet | 02321475 | ACT REPAGLINIDE | TEV |
ST0.5MG Tablet | 02355663 | APO-REPAGLINIDE | APX |
ST0.5MG Tablet | 02424258 | AURO-REPAGLINIDE | AUR |
ST0.5MG Tablet | 02239924 | GLUCONORM | NOO |
ST0.5MG Tablet | 02354926 | JAMP REPAGLINIDE | JMP |
ST0.5MG Tablet | 02415968 | REPAGLINIDE | PDL |
ST0.5MG Tablet | 02357453 | SANDOZ REPAGLINIDE | SDZ |
ST1MG Tablet | 02321483 | ACT REPAGLINIDE | TEV |
ST1MG Tablet | 02424266 | AURO-REPAGLINIDE | AUR |
ST1MG Tablet | 02239925 | GLUCONORM | NOO |
ST1MG Tablet | 02354934 | JAMP REPAGLINIDE | JMP |
ST1MG Tablet | 02415976 | REPAGLINIDE | PDL |
ST1MG Tablet | 02357461 | SANDOZ REPAGLINIDE | SDZ |
ST2MG Tablet | 02321491 | ACT REPAGLINIDE | TEV |
ST2MG Tablet | 02355698 | APO-REPAGLINIDE | APX |
ST2MG Tablet | 02424274 | AURO-REPAGLINIDE | AUR |
ST2MG Tablet | 02239926 | GLUCONORM | NOO |
ST2MG Tablet | 02354942 | JAMP REPAGLINIDE | JMP |
ST2MG Tablet | 02415984 | REPAGLINIDE | PDL |
ST2MG Tablet | 02357488 | SANDOZ REPAGLINIDE | SDZ |
68:20.18 SODIUM-GLUCOSE CONTRANSPORTER 2 (SGLT2) INHIBITORS
CANAGLIFLOZIN
Limited use benefit (prior approval required).
For the treatment of patients with type 2 diabetes mellitus who did not achieve glycemic control or who demonstrated intolerance to an adequate trial of metformin and a sulfonylurea.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST100MG Tablet | 02425483 | INVOKANA | JSO |
ST300MG Tablet | 02425491 | INVOKANA | JSO |
DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
Open benefit.
For the treatment of patients with type 2 diabetes mellitus who did not achieve glycemic control or who demonstrated intolerance to an adequate trial of metformin and a sulfonylurea.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST5MG Tablet | 02435462 | FORXIGA | AZC |
ST10MG Tablet | 02435470 | FORXIGA | AZC |
EMPAGLIFLOZIN
Open benefit.
For the treatment of type 2 diabetes mellitus:
- in patients who did not achieve glycemic control with an adequate trial of metformin and a sulfonylurea; or
- to reduce the incidence of cardiovascular death in patients with established cardiovascular disease who did not achieve adequate glycemic control despite an appropriate trial of metformin
Established cardiovascular disease is defined as one of the following:
- history of myocardial infarction
- multi-vessel coronary artery disease in two or more major coronary arteries (irrespective of revascularization status)
- single-vessel coronary artery disease with significant stenosis and either a positive non-invasive stress test or discharged from hospital with a documented diagnosis of unstable angina
- unstable angina with confirmed evidence of coronary multi-vessel or single-vessel disease
- history of ischemic or hemorrhagic stroke
- occlusive peripheral artery disease.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST10MG Tablet | 02443937 | JARDIANCE | BOE |
ST25MG Tablet | 02443945 | JARDIANCE | BOE |
METFORMIN HYDROCHLORIDE, DAPAGLIFLOZIN
Open benefit.
For the treatment of patients with type 2 diabetes mellitus who did not achieve glycemic control or who demonstrated intolerance to an adequate trial of metformin and a sulfonylurea.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST850MG & 5MG Tablet | 02449935 | XIGDUO | AZC |
ST1000MG & 5MG Tablet | 02449943 | XIGDUO | AZC |
METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN
Open benefit.
For the treatment of patients with type 2 diabetes mellitus in patients who are eligible to receive metformin and empagliflozin, to replace the individual components.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
500MG & 12.5MG Tablet | 02456605 | SYNJARDY | BOE |
500MG & 5MG Tablet | 02456575 | SYNJARDY | BOE |
850MG & 12.5MG Tablet | 02456613 | SYNJARDY | BOE |
850MG & 5MG Tablet | 02456583 | SYNJARDY | BOE |
1000MG & 12.5MG Tablet | 02456621 | SYNJARDY | BOE |
1000MG & 5MG Tablet | 02456591 | SYNJARDY | BOE |
68:20.20 ANTIDIABETIC AGENTS - SULFONYLUREAS
GLICLAZIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST80MG Tablet | 02245247 | APO-GLICLAZIDE | APX |
ST80MG Tablet | 00765996 | DIAMICRON | SEV |
ST80MG Tablet | 02248453 | GLICLAZIDE | PDL |
ST80MG Tablet | 02287072 | GLICLAZIDE | SAN |
ST80MG Tablet | 02238103 | TEVA-GLICLAZIDE | TEV |
ST30MG Tablet (Extended Release) | 02297795 | APO-GLICLAZIDE MR | APX |
ST30MG Tablet (Extended Release) | 02242987 | DIAMICRON MR | SEV |
ST30MG Tablet (Extended Release) | 02429764 | JAMP GLICLAZIDE-MR | JMP |
ST30MG Tablet (Extended Release) | 02423286 | MINT-GLICLAZIDE MR | MIN |
ST30MG Tablet (Extended Release) | 02438658 | MYLAN-GLICLAZIDE MR | MYL |
ST30MG Tablet (Extended Release) | 02461323 | SANDOZ GLICLAZIDE MR | SDZ |
ST30MG Tablet (Extended Release) | 02463571 | TARO-GLICLAZIDE MR | SUN |
ST60MG Tablet (Extended Release) | 02407124 | APO-GLICLAZIDE MR | APX |
ST60MG Tablet (Extended Release) | 02356422 | DIAMICRON MR | SEV |
ST60MG Tablet (Extended Release) | 02423294 | MINT-GLICLAZIDE MR | MIN |
ST60MG Tablet (Extended Release) | 02439328 | RAN-GLICLAZIDE | SUN |
ST60MG Tablet (Extended Release) | 02461331 | SANDOZ GLICLAZIDE MR | SDZ |
GLYBURIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST2.5MG Tablet | 01913654 | APO GLYBURIDE | APX |
ST2.5MG Tablet | 01959352 | GLYBURIDE | PDL |
ST2.5MG Tablet | 02350459 | GLYBURIDE | SAN |
ST2.5MG Tablet | 01913670 | TEVA-GLYBURIDE | TEV |
ST5MG Tablet | 01913662 | APO GLYBURIDE | APX |
ST5MG Tablet | 02234514 | DOM-GLYBURIDE | DPC |
ST5MG Tablet | 00720941 | EUGLUCON | PMS |
ST5MG Tablet | 02350467 | GLYBURIDE | SAN |
ST5MG Tablet | 02236734 | PMS-GLYBURIDE | PMS |
ST5MG Tablet | 01913689 | TEVA-GLYBURIDE | TEV |
68:20.28 THIAZOLIDINEDIONES
PIOGLITAZONE HYDROCHLORIDE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST15MG Tablet | 02391600 | ACH-PIOGLITAZONE | ACC |
ST15MG Tablet | 02302861 | ACT PIOGLITAZONE | TEV |
ST15MG Tablet | 02302942 | APO-PIOGLITAZONE | APX |
ST15MG Tablet | 02397307 | JAMP-PIOGLITAZONE | JMP |
ST15MG Tablet | 02326477 | MINT-PIOGLITAZONE | MIN |
ST15MG Tablet | 02303124 | PMS-PIOGLITAZONE | PMS |
ST15MG Tablet | 02312050 | PRO-PIOGLITAZONE | PDL |
ST15MG Tablet | 02375850 | RAN-PIOGLITAZONE | RBY |
ST15MG Tablet | 02297906 | SANDOZ PIOGLITAZONE | SDZ |
ST30MG Tablet | 02339587 | ACH-PIOGLITAZONE | ACC |
ST30MG Tablet | 02302888 | ACT PIOGLITAZONE | TEV |
ST30MG Tablet | 02302950 | APO-PIOGLITAZONE | APX |
ST30MG Tablet | 02365529 | JAMP-PIOGLITAZONE | JMP |
ST30MG Tablet | 02326485 | MINT-PIOGLITAZONE | MIN |
ST30MG Tablet | 02303132 | PMS-PIOGLITAZONE | PMS |
ST30MG Tablet | 02312069 | PRO-PIOGLITAZONE | PDL |
ST30MG Tablet | 02375869 | RAN-PIOGLITAZONE | RBY |
ST30MG Tablet | 02297914 | SANDOZ PIOGLITAZONE | SDZ |
ST45MG Tablet | 02339595 | ACH-PIOGLITAZONE | ACC |
ST45MG Tablet | 02302896 | ACT PIOGLITAZONE | TEV |
ST45MG Tablet | 02302977 | APO-PIOGLITAZONE | APX |
ST45MG Tablet | 02365537 | JAMP-PIOGLITAZONE | JMP |
ST45MG Tablet | 02326493 | MINT-PIOGLITAZONE | MIN |
ST45MG Tablet | 02303140 | PMS-PIOGLITAZONE | PMS |
ST45MG Tablet | 02312077 | PRO-PIOGLITAZONE | PDL |
ST45MG Tablet | 02375877 | RAN-PIOGLITAZONE | RBY |
ST45MG Tablet | 02297922 | SANDOZ PIOGLITAZONE | SDZ |
68:22.12 GLYCOGENOLYTIC AGENTS
GLUCAGON RECOMBINANT DNA ORGIN
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
1MG/ML Injection | 02333619 | GLUCAGEN | NOO |
1MG/ML Injection | 02333627 | GLUCAGEN HYPOKIT | NOO |
1MG/ML Injection | 02243297 | GLUCAGON | LIL |
68:24.00 PARATHYROID
CALCITONIN SALMON (SYNTHETIC)
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
200IU/ML Solution | 01926691 | CALCIMAR | SAC |
68:28.00 PITUITARY
DESMOPRESSIN ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
4MCG/ML Liquid | 00873993 | DDAVP | FEI |
0.1MG/ML Nasal Spray | 00402516 | DDAVP | FEI |
0.1MG/ML Nasal Spray | 00836362 | DDAVP | FEI |
0.1MG/ML Nasal Spray | 02242465 | DESMOPRESSIN | AAP |
ST0.1MG Tablet | 00824305 | DDAVP | FEI |
ST0.1MG Tablet | 02284030 | DESMOPRESSIN | APX |
ST0.1MG Tablet | 02304368 | PMS-DESMOPRESSIN | PMS |
ST0.1MG Tablet | 02287730 | TEVA-DESMOPRESSIN | TEV |
ST0.2MG Tablet | 00824143 | DDAVP | FEI |
ST0.2MG Tablet | 02284049 | DESMOPRESSIN | APX |
ST60MCG Tablet (Orally Disintegrating) | 02284995 | DDAVP MELT | FEI |
ST120MCG Tablet (Orally Disintegrating) | 02285002 | DDAVP MELT | FEI |
ST240MCG Tablet (Orally Disintegrating) | 02285010 | DDAVP MELT | FEI |
68:32.00 PROGESTINS
DIENOGEST
Limited use benefit (prior approval required).
For the management of pelvic pain associated with endometriosis.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST2MG Tablet | 02493055 | ASPEN-DIENOGEST | UNK |
ST2MG Tablet | 02374900 | VISANNE | BAY |
MEDROXYPROGESTERONE ACETATE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
150MG/ML Suspension | 00585092 | DEPO-PROVERA | PFI |
150MG/ML Suspension | 02322250 | MEDROXYPROGESTERONE | SDZ |
ST2.5MG Tablet | 02244726 | APO-MEDROXY | APX |
ST2.5MG Tablet | 02253550 | MEDROXY | PDL |
ST2.5MG Tablet | 00708917 | PROVERA | PFI |
ST2.5MG Tablet | 02221284 | TEVA-MEDROXYPROGESTERONE | TEV |
ST5MG Tablet | 02244727 | APO-MEDROXY | APX |
ST5MG Tablet | 02253577 | MEDROXY | PDL |
ST5MG Tablet | 00030937 | PROVERA | PFI |
ST5MG Tablet | 02221292 | TEVA-MEDROXYPROGESTERONE | TEV |
ST10MG Tablet | 02277298 | APO-MEDROXY | APX |
ST10MG Tablet | 00729973 | PROVERA | PFI |
ST10MG Tablet | 02221306 | TEVA-MEDROXYPROGESTERONE | TEV |
ST100MG Tablet | 02267640 | APO-MEDROXY | APX |
PROGESTERONE
Limited use benefit (prior approval required).
For the treatment of clients:
- with postmenopausal symptoms who are intolerant to medroxyprogesterone acetate (MPA); or
- who are at risk of preterm birth; or
- who are using the medication to prevent miscarriage.
In adults:
- for use as Gender Affirming Hormone Therapy.
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
100MG Capsule | 02476576 | PMS-PROGESTERONE | PMS |
ST100MG Capsule | 02166704 | PROMETRIUM | FRS |
ST100MG Capsule | 02463113 | REDDY-PROGESTERONE | REC |
ST100MG Capsule | 02439913 | TEVA-PROGESTERONE | TEV |
68:36.04 THYROID AGENTS
LEVOTHYROXINE SODIUM
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST0.025MG Tablet | 02172062 | SYNTHROID | BGP |
ST0.05MG Tablet | 02213192 | ELTROXIN | ASP |
ST0.05MG Tablet | 02172070 | SYNTHROID | BGP |
ST0.075MG Tablet | 02172089 | SYNTHROID | BGP |
ST0.088MG Tablet | 02172097 | SYNTHROID | BGP |
ST0.1MG Tablet | 02213206 | ELTROXIN | ASP |
ST0.1MG Tablet | 02172100 | SYNTHROID | BGP |
ST0.112MG Tablet | 02171228 | SYNTHROID | BGP |
ST0.125MG Tablet | 02172119 | SYNTHROID | BGP |
ST0.137MG Tablet | 02233852 | SYNTHROID | BGP |
ST0.15MG Tablet | 02213214 | ELTROXIN | ASP |
ST0.15MG Tablet | 02172127 | SYNTHROID | BGP |
ST0.175MG Tablet | 02172135 | SYNTHROID | BGP |
ST0.2MG Tablet | 02213222 | ELTROXIN | ASP |
ST0.2MG Tablet | 02172143 | SYNTHROID | BGP |
ST0.3MG Tablet | 02172151 | SYNTHROID | BGP |
LIOTHYRONINE SODIUM
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST5MCG Tablet | 01919458 | CYTOMEL | PFI |
ST25MCG Tablet | 01919466 | CYTOMEL | PFI |
THYROID
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST30MG Tablet | 00023949 | THYROID | ERF |
ST60MG Tablet | 00023957 | THYROID | ERF |
ST125MG Tablet | 00023965 | THYROID | ERF |
68:36.08 ANTITHYROID AGENTS
METHIMAZOLE
Drug strength and dosage form | DIN | Brand name | Manufacturer code |
---|---|---|---|
ST5MG Tablet | 02480107 | MAR-METHIMAZOLE | MAR |
ST5MG Tablet | 00015741 | TAPAZOLE | PAL |
ST10MG Tablet | 02480115 | MAR-METHIMAZOLE | MAR |
ST10MG Tablet | 02296039 | TAPAZOLE | PAL |